Lv6
2320 积分 2022-11-10 加入
Defining immune reset: achieving sustained remission in autoimmune diseases
13天前
已完结
Rare oncology therapeutics: review of clinical pharmacology package of drug approvals (2019–2023) by US FDA, best practices and recommendations
23天前
已完结
Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers
23天前
已完结
Lupus Nephritis: New and Emerging Biologic and Targeted Therapies
23天前
已完结
Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody
1个月前
已完结
The Mannose in the Mirror: A Reflection on the Pharmacokinetic Impact of High Mannose Glycans of Monoclonal Antibodies in Biosimilar Development
1个月前
已完结
ADCC enhancement: A conundrum or a boon to mAb therapy?
1个月前
已完结
Industrial bioprocessing perspectives on managing therapeutic protein charge variant profiles
1个月前
已完结
Protein loss during membrane processes in biopharmaceutical manufacturing
1个月前
已完结
The downstream purification of bispecific antibodies
1个月前
已完结
Surface electron doping induced double gap opening in T d-WTe2
皖公网安备34019202002308
